-
N-{3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}-6-(2-{[(2-methanesulfonylethyl)amino]methyl}-1,3-thiazol-4-yl)quinazolin-4-amine dihydrochloride
-
ChemBase ID:
154396
-
Molecular Formular:
C28H27Cl3FN5O3S2
-
Molecular Mass:
671.0330832
-
Monoisotopic Mass:
669.06049301
-
SMILES and InChIs
SMILES:
CS(=O)(=O)CCNCc1nc(cs1)c1ccc2c(c1)c(ncn2)Nc1ccc(c(c1)Cl)OCc1cccc(c1)F.Cl.Cl
Canonical SMILES:
Fc1cccc(c1)COc1ccc(cc1Cl)Nc1ncnc2c1cc(cc2)c1csc(n1)CNCCS(=O)(=O)C.Cl.Cl
InChI:
InChI=1S/C28H25ClFN5O3S2.2ClH/c1-40(36,37)10-9-31-14-27-35-25(16-39-27)19-5-7-24-22(12-19)28(33-17-32-24)34-21-6-8-26(23(29)13-21)38-15-18-3-2-4-20(30)11-18;;/h2-8,11-13,16-17,31H,9-10,14-15H2,1H3,(H,32,33,34);2*1H
InChIKey:
WIMITXDBYLKRKB-UHFFFAOYSA-N
-
Cite this record
CBID:154396 http://www.chembase.cn/molecule-154396.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
|
IUPAC name
|
|
N-{3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}-6-(2-{[(2-methanesulfonylethyl)amino]methyl}-1,3-thiazol-4-yl)quinazolin-4-amine dihydrochloride
|
|
|
|
|
IUPAC Traditional name
|
|
N-{3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}-6-(2-{[(2-methanesulfonylethyl)amino]methyl}-1,3-thiazol-4-yl)quinazolin-4-amine dihydrochloride
|
|
|
|
|
Synonyms
|
|
4-[3-Chloro-4-[(3-fluorophenyl)methoxy]phenylamino]-6-[2-[[2-(methylsulfonyl)ethyl]aminomethyl]-4-thiazolyl]quinazoline dihydrochloride
|
|
GW583340 dihydrochloride
|
|
|
|
|
MDL Number
|
|
|
PubChem SID
|
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
|
Acid pKa
|
15.993641
|
H Acceptors
|
8
|
H Donor
|
2
|
LogD (pH = 5.5)
|
3.484543
|
LogD (pH = 7.4)
|
4.6855364
|
Log P
|
4.7760706
|
Molar Refractivity
|
154.3122 cm3
|
Polarizability
|
62.217785 Å3
|
Polar Surface Area
|
106.1 Å2
|
Rotatable Bonds
|
11
|
Lipinski's Rule of Five
|
false
|
DETAILS
DETAILS
Sigma Aldrich
Sigma Aldrich -
G3545
|
Biochem/physiol Actions Potent dual ErbB-2/EGFR tyrosine kinase inhibitor. IC50= 0.01 and 0.014 μM for EGFR and ErbB-2. Orally active. Legal Information Sold for research purposes under agreement from Glaxo-Smith-Kline |
PATENTS
PATENTS
PubChem Patent
Google Patent